Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by westcoast1000


T.ONC

RE:Merck KGaA partners on liquid biopsy in cancer diagnostics

I felt that it was a genius move for ONCY to put in the time and effort to...

September 1, 2022

T.ONC

RE:RE:RE:What's up Doc?

I share that same feeling, cardu.

August 31, 2022

T.ONC

RE:What's up Doc?

Well, cardu, the feeling by some is that the lack of information on which we...

August 31, 2022

T.ONC

RE:RE:RE:AstraZeneca paid USD$ 5.5 Billion to co-market Enhertu

Noteable, Thanks for this helpful insight on ONCY and CAR-T potential. This...

August 28, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:BMS acquires Turning Point's TKI platform for USD$ 4.8 Bln

What is the definition of "biobucks"?

August 20, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:BMS acquires Turning Point's TKI platform for USD$ 4.8 Bln

Calling pela an IMMUNE PLATFORM MOLECULE makes complete sense to me. It is...

August 20, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:BMS acquires Turning Point's TKI platform for USD$ 4.8 Bln

Thanks for these interesting findings Noteable. It has been 8 years since the...

August 19, 2022

T.ONC

RE:Institutional Ownership

Thanks for the useful new information about institutional ownership. I count...

August 17, 2022

T.ONC

Value proposition: cost and opportunity

Given the relatively low share count and the stunningly but persistently low...

August 17, 2022

T.ONC

RE:RE:New here

Askretka, I share your view about ONCY as an opportunity of a lifetime. But...

August 17, 2022

T.ONC

RE:RE:RE:My post about someone wanting to control this stock vanished

Found it below Buckhenry's,

August 16, 2022

T.ONC

RE:RE:My post about someone wanting to control this stock vanished

I saw it below within the hour.

August 16, 2022

T.ONC

RE:RE:RE:RE:RE:More questions for Notable

Sorry about that mistake.

August 16, 2022

T.ONC

RE:New here

Gazzman, It is a long long story. I recommend listening to the recent...

August 16, 2022

T.ONC

RE:RE:More questions for Notable

Thanks very much for your replies. They help understand things here.

August 16, 2022

T.ONC

More questions for Notable

Notable, I, and I expect many others, are grateful for your posts, which...

August 16, 2022

T.ONC

RE:RE:Q for notable

Thanks, Notalbe. That factor alone should clearly contribute substantially...

August 14, 2022

NEVDQ

RE:NCU Random notes

Thanks once again, Roy. You have some of the most informative and clear...

August 14, 2022

T.ONC

Q for notable

If someone like Roche licenses (or buys) Pncy and pela, should I presume they...

August 14, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:Get ready for more merger mania in the pharma sector

Thumbs up to the posts from Capitalista and Notable just below. If it goes as...

August 14, 2022